Fora Capital, LLC Ascendis Pharma A/S Transaction History

Fora Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$123.45 - $159.4 $573,919 - $741,050	4,649 New	4,649 $702,000
Q2 2022 Aug 11, 2022	SELL	$78.08 - $117.61 $780,800 - $1.18 Million	-10,000 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$102.18 - $135.75 $1.02 Million - $1.36 Million	10,000 New	10,000 $1.16 Million
Q2 2021 Aug 16, 2021	SELL	$121.62 - $145.29 $123,444 - $147,469	-1,015 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$124.92 - $173.33 $126,793 - $175,929	1,015 New	1,015 $131 Million
Q3 2020 Nov 13, 2020	SELL	$134.29 - $154.32 $67,279 - $77,314	-501 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $55,545 - $78,161	501 New	501 $74 Million

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.